T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Tesla
TSLA
|
+$5.14B |
| 2 |
JPMorgan Chase
JPM
|
+$2.05B |
| 3 |
Atlassian
TEAM
|
+$2.04B |
| 4 |
NVIDIA
NVDA
|
+$1.97B |
| 5 |
Apple
AAPL
|
+$1.73B |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.32B |
| 2 |
Microsoft
MSFT
|
+$2.74B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.74B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.9B |
| 5 |
Hilton Worldwide
HLT
|
+$1.79B |
Sector Composition
| 1 | Technology | 26.88% |
| 2 | Healthcare | 17.2% |
| 3 | Consumer Discretionary | 15.14% |
| 4 | Financials | 10.69% |
| 5 | Communication Services | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Willdan Group
WLDN
$1.5B
| $323K | ﹤0.01% |
10,520
-3,755
| -26% | -$115K |
|
2502
Lexicon Pharmaceuticals
LXRX
$407M
| $322K | ﹤0.01% |
153,932
+10,300
| +7% | +$21.5K |
|
2503
WisdomTree
WT
$2.05B
| $321K | ﹤0.01% |
54,741
+3,110
| +6% | +$18.2K |
|
2504
Bandwidth Inc
BAND
$460M
| $320K | ﹤0.01% |
9,885
-1,452
| -13% | -$47K |
|
|
AAIC
2505
DELISTED
Arlington Asset Investment Corp.
AAIC
| $320K | ﹤0.01% |
92,100
| – | – |
|
2506
TaskUs
TASK
$1.56B
| $319K | ﹤0.01% |
8,300
+2,000
| +32% | +$76.9K |
|
|
AVID
2507
DELISTED
Avid Technology Inc
AVID
| $318K | ﹤0.01% |
9,117
+768
| +9% | +$26.8K |
|
|
CANO
2508
DELISTED
Cano Health, Inc.
CANO
| $318K | ﹤0.01% |
501
+174
| +53% | +$110K |
|
2509
ACM Research
ACMR
$1.89B
| $317K | ﹤0.01% |
15,300
+5,700
| +59% | +$118K |
|
|
ANAT
2510
DELISTED
American National Group, Inc. Common Stock
ANAT
| $317K | ﹤0.01% |
1,674
-736
| -31% | -$139K |
|
2511
Gorman-Rupp
GRC
$1.13B
| $316K | ﹤0.01% |
8,798
+1,356
| +18% | +$48.7K |
|
2512
Talos Energy
TALO
$1.7B
| $316K | ﹤0.01% |
20,009
-7,654
| -28% | -$121K |
|
|
CNSL
2513
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $316K | ﹤0.01% |
53,639
+1,768
| +3% | +$10.4K |
|
|
ACR
2514
ACRES Commercial Realty
ACR
$157M
| $312K | ﹤0.01% |
23,265
-2,700
| -10% | -$36.2K |
|
|
BCLI
2515
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $312K | ﹤0.01% |
6,200
| – | – |
|
2516
Blink Charging
BLNK
$140M
| $309K | ﹤0.01% |
11,696
+1,813
| +18% | +$47.9K |
|
2517
eHealth
EHTH
$119M
| $308K | ﹤0.01% |
24,826
-146,389
| -86% | -$1.82M |
|
2518
Vaxcyte
PCVX
$4.26B
| $307K | ﹤0.01% |
12,708
+1,127
| +10% | +$27.2K |
|
|
WW
2519
DELISTED
WW International
WW
| $306K | ﹤0.01% |
29,881
+13,060
| +78% | +$134K |
|
|
EVOP
2520
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $306K | ﹤0.01% |
13,253
+3,328
| +34% | +$76.8K |
|
|
SRNE
2521
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $305K | ﹤0.01% |
130,715
+18,809
| +17% | +$43.9K |
|
2522
PC Connection
CNXN
$1.61B
| $302K | ﹤0.01% |
+5,756
| New | +$302K |
|
2523
Olema Pharmaceuticals
OLMA
$553M
| $302K | ﹤0.01% |
70,872
+700
| +1% | +$2.98K |
|
2524
PMV Pharmaceuticals
PMVP
$68.4M
| $302K | ﹤0.01% |
14,504
-36,720
| -72% | -$765K |
|
2525
Sylvamo
SLVM
$1.76B
| $302K | ﹤0.01% |
9,068
-29,819
| -77% | -$993K |
|